Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.085
Buy
RSI(14)
55.037
Neutral
STOCH(KDJ)(9,3,3)
51.586
Sell
ATR(14)
0.310
Low Volatility
CCI(14)
21.744
Neutral
Williams %R
28.571
Buy
TRIX(12,20)
0.609
Sell
StochRSI(14)
8.685
Sell
Search
Inventiva SA
IVAAdd to Watchlist
4.460USD
-0.050-1.11%
Close 07-24 16:00（ET）Quotes delayed by 15 min
861.84MMarket Cap
--P/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-1.11%
5 Days
-3.46%
1 Month
+27.43%
6 Months
-37.62%
Year to Date
-4.09%
1 Year
+40.85%
Key Figures
4.440Open
4.545High
667.37KVolume
--P/E TTM
LossP/E Dynamic
--Dividend TTM
0.35%Turnover Ratio
4.510Prev. Close
4.380Low
2.14MTurnover
--P/E Static
-25.73P/B
0.00%Div Yield TTM
--ROA
7.98252wk High
0.97Volume Ratio
--Net Profit
193.24MShares
--EPS TTM
0.70Beta
--ROE
2.85452wk Low
3.66%Amplitude
--Gross Margin
861.84MMarket Cap
7.44Reward/Risk
4.34%Risk Rate
Inventiva SA News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
13
analysts
Strong Buy
Current Rating
12.308
Target Price
+172.91%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Inventiva SA
IVA
13
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
Insmed Inc
INSM
23
1
2
3
...
99
Indicators
Moving Average
Indicators
Value
Direction
MA5
4.481
Sell
MA10
4.472
Sell
MA20
4.237
Buy
MA50
4.325
Buy
MA100
4.989
Sell
MA200
5.081
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Inventiva SA Info
Inventiva SA is a France-based company engaged in the biotechnology sector. The Company focuses on the development of therapies in the area of oncology, fibrosis and rare diseases. The Company’s pipeline comprises a number of development programs, such as Clinical Pipeline, Preclinical Pipeline, AbbVie Collaboration and Boehringer-Ingelheim collaboration. Its drug candidates target at the treatment of non-alcoholic steatohepatitis (NASH), systemic sclerosis (SSc), various types of mucopolysaccharidosis (MPS), multiple myeloma, auto-immune disorders, as well as lung cancer, among others. In addition, the Company offers drug discovery services, ranging from target identification to preclinical nomination, in numerous areas, such as silico modelling, biology, screening, absorption, distribution, metabolism and excretion (ADME), pharmacology and histology.
Ticker SymbolIVA
CompanyInventiva SA
CEOObenshain (Andrew)
Websitehttps://inventivapharma.com/
Shareholders
Related Instruments
+0.88%
+1.60%
+0.43%
+0.90%
+0.46%
-0.72%
+1.22%
+1.25%
-1.18%
-0.12%
+0.94%
+0.90%
+1.20%
-0.02%
+2.04%
0.00%
+0.63%
-0.69%
+2.59%
+0.89%Popular Instruments
51900.000
+176.000 (+0.34%)
28150.400
-427.600 (-1.50%)
7408.100
-11.800 (-0.16%)
14948.000
-153.000 (-1.01%)
64219.000
-1152.000 (-1.76%)
6264.500
+48.800 (+0.79%)
90.043
-2.069 (-2.25%)
333.020
+11.360 (+3.53%)
206.840
-1.920 (-0.92%)
4052.350
+2.980 (+0.07%)
FAQs
What is the current price of Inventiva SA (IVA)?
The current price of Inventiva SA (IVA) is 4.46.
What is the symbol of Inventiva SA?
The ticker symbol of Inventiva SA is IVA.
What is the 52-week high of Inventiva SA?
The 52-week high of Inventiva SA is 7.98.
What is the 52-week low of Inventiva SA?
The 52-week low of Inventiva SA is 2.85.
What is the market capitalization of Inventiva SA?
The market capitalization of Inventiva SA is 1.03B.
Is Inventiva SA (IVA) currently rated as Buy, Hold, or Sell?
According to analysts, Inventiva SA (IVA) has an overall rating of STRONG BUY, with a price target of 12.31.
What is the Earnings Per Share (EPS TTM) of Inventiva SA (IVA)?
The Earnings Per Share (EPS TTM) of Inventiva SA (IVA) is -2.14.